RECURRENT GROUP 4 (NON-SHH/NON-WNT) MEDULLOBLASTOMA

Clinical trials for RECURRENT GROUP 4 (NON-SHH/NON-WNT) MEDULLOBLASTOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT GROUP 4 (NON-SHH/NON-WNT) MEDULLOBLASTOMA trials appear

Sign up with your email to follow new studies for RECURRENT GROUP 4 (NON-SHH/NON-WNT) MEDULLOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

Pioneering immune therapy trial offers new hope for kids with recurrent brain cancer

Disease control Ongoing

This is a small, early-stage study testing a complex, personalized immune therapy for children and young adults whose medulloblastoma, a type of brain cancer, has come back. The goal is to see if it's safe and possible to combine several treatments: a custom-made vaccine, special…

Matched conditions: RECURRENT GROUP 4 (NON-SHH/NON-WNT) MEDULLOBLASTOMA

Phase: PHASE1 • Sponsor: University of Florida • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

RECURRENT GROUP 4 (NON-SHH/NON-WNT) MEDULLOBLASTOMA

Get alerted when new RECURRENT GROUP 4 (NON-SHH/NON-WNT) MEDULLOBLASTOMA trials appear

Pioneering immune therapy trial offers new hope for kids with recurrent brain cancer